Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL822920 | 0.89 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL27495273 | 0.87 | MEN1 (0.44) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL28917001 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL6560066 | 0.84 | ALDH1A1 (0.39) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL4116529 | 0.84 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL5942244 | 0.82 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL4855444 | 0.82 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL22176956 | 0.82 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL28916975 | 0.82 | GRIN2D (0.37) | ALDH1A1MEN1KMT2AL3MBTL1TSHR | |
| SCHEMBL16708446 | 0.82 | ALDH1A1 (0.39) | ALDH1A1MEN1KMT2AL3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118265229-A | Method for manufacturing laminate and semiconductor package | 富士胶片株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-117471851-A | Method for manufacturing laminate including conductive pattern, and method for manufacturing touch panel | 富士胶片株式会社 | 2024-01-30 | — | — | CN | disclosed |
| CN-116157264-A | Transfer film, method for producing laminate, and method for producing circuit wiring | 富士胶片株式会社 | 2023-05-23 | — | — | CN | disclosed |
| CN-116157741-A | Transfer film, method for producing laminate, and method for producing circuit wiring | 富士胶片株式会社 | 2023-05-23 | — | — | CN | disclosed |
| CN-115685693-A | Method for manufacturing laminate including transparent conductive pattern and method for manufacturing touch panel | 富士胶片株式会社 | 2023-02-03 | — | — | CN | disclosed |
| CN-115542669-A | Laminate, transfer film, pattern forming method, and method for manufacturing circuit board | 富士胶片株式会社 | 2022-12-30 | — | — | CN | disclosed |
| CN-115480451-A | Laminate, substrate with transparent conductive layer, and pattern formation method | 富士胶片株式会社 | 2022-12-16 | — | — | CN | disclosed |
| CN-115480446-A | Transfer film, laminate, pattern forming method, and method for manufacturing circuit board | 富士胶片株式会社 | 2022-12-16 | — | — | CN | disclosed |
| US-8173350-B2 | Oxime compound and resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8173350-B2 | Oxime compound and resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100021847-A1 | Oxime Compound and Resist Composition Containing the Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| US-20100021847-A1 | Oxime Compound and Resist Composition Containing the Same | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100021847-A1 | Oxime Compound and Resist Composition Containing the Same | CYC1, UQCRB, CBR1 | ALDH1A1 1280/4885MEN1 1580/4885KMT2A 878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.